Leukoencephalopathies associated with inborn errors of metabolism in adults

Journal of Inherited Metabolic Disease

Volumn 31, Issue 3, 2008, Pages 295-307

  Sedel, Frederic ^a,b   Tourbah, A ^b,c   Fontaine, B ^a,b   Lubetzki, C ^b   Baumann, N ^b   Saudubray, J M ^d   Lyon Caen, O ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CARNITINE; CHENODEOXYCHOLIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLINIC ACID; GADOLINIUM; HYDROXOCOBALAMIN; LORENZO OIL; RIBOFLAVIN; ZILEUTON;

ADRENOLEUKODYSTROPHY; ADULT; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW TRANSPLANTATION; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME REPLACEMENT; FABRY DISEASE; GLOBOID CELL LEUKODYSTROPHY; HUMAN; INBORN ERROR OF METABOLISM; LEUKOENCEPHALOPATHY; METACHROMATIC LEUKODYSTROPHY; METHYLENETETRAHYDROFOLATE DEFICIENCY; MUCOLIPIDOSIS TYPE 4; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENYLKETONURIA; POLYGLUCOSAN BODY DISEASE; REVIEW; SJOEGREN LARSSON SYNDROME;

ADRENOLEUKODYSTROPHY; BRAIN DISEASES, METABOLIC, INBORN; ELECTRON TRANSPORT; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HOMOCYSTEINE; HUMANS; LEUKODYSTROPHY, GLOBOID CELL; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; PHENYLKETONURIAS; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 45849120948     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0778-0     Document Type: Review

References (70)

1. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al (1992) Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 42: 85-91.
2. Bach G (2001) Mucolipidosis type IV. Mol Genet Metab 73: 197-203.
3. Bajaj NPS, Waldmann A, Orrell B, Wood NW, Bhatia KP (2002) Familial adult onset of Krabbe's disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry 72: 635-638.
4. Barkhof F, Verrips A, Wesseling P, et al (2000) Cerebrotendinous xanthomatosis: The spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217: 869-876.
5. Bataillard M, Richard P, Rumbach L, Vanier MT, Truttmann M (1997) Isolated spastic paraparesis disclosing Krabbe disease in adult age. Rev Neurol (Paris) 153: 347-350.
6. Baumann N, Turpin JC (2000) Adult-onset leukodystrophies. J Neurol 247: 751-759.
7. Baumann N, Masson M, Carreau V, Lefevre M, Hersckowitz N, Turpin JC (1991) Adult forms of metachromatic leukodystrophy: Clinical and biochemical approach. Dev Neurosci 13: 211-215.
8. Baumgartner MR, Poll-The BT, Verhoeven NM, et al (1998) Clinical approach to inherited peroxisomal disorders: A series of 27 patients. Ann Neurol 44: 720-730.
9. Berkhoff M, Weis J, Schroth G, Sturzenegger M (2001) Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology 43: 234-236.
10. Bianchi MC, Tosetti M, Battini R (2003) Proton MR spectroscopy of mitochondrial diseases: Analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 24: 1958-1966.
11. Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A (2004) 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy. Ann Neurol 56: 727-730.
12. Bjorkhem I, Muri Boberg K, Leitersdorf E (2001) Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2961-2988.
13. Bosch EP, Hart MN (1978) Late adult-onset metachromatic leucodystrophy. Dementia and polyneuropathy in a 63-year-old-man. Arch Neurol 35: 475-477.
14. Boxer AL, Kramer JH, Johnston K, Goldman J, Finley R, Miller BL (2005) Executive dysfunction in hyperhomocystinemia responds to homocysteine lowering treatment. Neurology 64: 1431-1434.
15. Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284: 2771-2775.
16. Deconinck N, Messaaoui A, Ziereisen F, et al (2007) Metachromatic leukodystrophy without arylsulfatase A deficiency: A new case of saposin-B deficiency. Eur J Paediatr Neurol [E-pub ahead of print].
17. Eichler F, Mahmood A, Loes D, et al (2007) Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 64: 659-664.
18. Eriguchi M, Mizuta H, Kurohara K, et al (2006) 3-Methylglutaconic aciduria type I causes leukoencephalopathy of adult onset. Neurology 67: 1895-1896.
19. Farina L, Bizzi A, Finocchiaro G, et al (2000) MR imaging and proton MR spectroscopy in adult Krabbe disease. Am J Neuroradiol 21: 1478-1482.
20. Fellgiebel A, Muller MJ, Mazanek M, Baron K, Beck M, Stoeter P (2005) White matter lesion severity in male and female patients with Fabry disease. Neurology 23: 65: 600-602.
21. Filley CM, Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345: 425-432.
22. Finsterer J (2006) Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 114: 217-238.
23. Fontaine B, Thenin JP, Viader F (2003) Gait disorders with insidious progression in a 60-year old woman. Rev Neurol (Paris) 159: 695-699.
24. Frei KP, Patronas NJ, Crutchfield KE, Altarescu G, Schiffmann R (1998) Mucolipidosis type IV: Characteristic MRI findings. Neurology 51: 565-569.
25. Grunewald S, Champion MP, Leonard JV, Schaper J, Morris AA (2004) Biotinidase deficiency: A treatable leukoencephalopathy. Neuropediatrics 35: 211-216.
26. Harzer K, Knoblich R, Rolfs A, Bauer P, Eggers J (2002) Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease. Clin Chim Acta 317: 77-84.
27. Henderson RD, MacMillan JC, Bradfield JM (2003) Adult onset Krabbe disease may mimic motor neurone disease. J Clin Neurosci 10: 638-639.
28. Hirano M, Silvestri G, Blake DM, et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44: 721-727.
29. Hörster F, Surtees R, Hoffmann GF (2005) Disorders of intermediary metabolism: Toxic leukoencephalopathies. J Inherit Metab Dis 28: 345-356.
30. Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS (2004) Ribose-5-phosphate isomerase deficiency: New inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 74: 745-751.
31. Janson CG, Kolodny EH, Zeng BJ, et al (2006) Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene. Ann Neurol 59: 428-431.
32. Jaros E, Mahad DJ, Hudson G, et al (2007) Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy. Neurology 69: 214-216.
33. Kasim S, Moo LR, Zschocke J, Jinnah HA (2001) Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia. J Neurol Neurosurg Psychiatry 71: 795-797.
34. Kidd D, Nelson J, Jones F, et al (1998) Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol 55: 98-99.
35. Kiselyov K, Soyombo A, Muallem S (2007) TRPpathies. J Physiol 578: 641-653.
36. Krivit W, Shapiro EG, Peters C, et al (1998) Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 338: 1119-1126.
37. Kulkens S, Harting I, Sauer S, et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142-2144.
38. Kuriyama M, Fujiyama J, Yoshidome H, et al (1991) Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci 102: 225-232.
39. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D (2005) White matter involvement in mitochondrial diseases. Mol Genet Metab 84: 127-136.
40. Lin DD, Crawford TO, Barker PB (2003) Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 24: 33-41.
41. Lorincz MT, Rainier S, Thomas D, Fink JK (2005) Cerebrotendinous xanthomatosis. Possible higher prevalence than previously recognized. Arch Neurol 62: 1459-1463.
42. McCombe PA, McLaughlin DB, Chalk JB, Brown NN, McGill JJ, Pender MP (1992) Spasticity and white matter abnormalities in adult phenylketonuria. J Neurol Neurosurg Psychiatry 55: 359-361.
43. Menage P, Carreau V, Tourbah A, et al (1993) [Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases] [In French]. Rev Neurol (Paris) 149: 445-454.
44. Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry's disease. Ann Neurol 40: 8-17.
45. Moser AB, Rasmussen M, Naidu S, et al (1995) Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127: 13-22.
46. Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3: 140-151.
47. Ogier de Baulny H, Gerard M, Saudubray JM, Zittoun J (1998) Remethylation defects: Guidelines for clinical diagnosis and treatment. Eur J Pediatr 157 (Supplement 2): S77-83.
48. Owens WE, Okun MS (2004) Dystonia, tremor, and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria. J Neurol Neurosurg Psychiatry 75: 1362-1363.
49. Rauschka H, Colsch B, Baumann N, et al (2006) Late-onset metachromatic leukodystrophy: Genotype strongly influences phenotype. Neurology 67: 859-863.
50. Reis S, Sheffer RN, Merin S, Luder AS, Bach G (1993) Mucolipidosis type IV: A mild form with late onset. Am J Med Genet 47: 392-394.
51. Sabatelli M, Quaranta L, Madia F, et al (2002) Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe's disease. Neuromuscul Disord 12: 386-391.
52. Sakakibara R, Fukutake T, Arai K, Katayama K, Mori M, Hattori T (2001) Unilateral caudate head lesion stimulating brain tumour in X-linked adult onset adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 70: 414-415.
53. Schiffmann R, van der Knaap MS (2004) The latest on leukodystrophies. Curr Opin Neurol 17: 187-192.
54. Schiffmann R, Dwyer NK, Lubensky IA, et al (1998) Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A 95: 1207-1212.
55. Sedel F, Tourbah A, Baumann N, et al (2005) Adult onset leukodystrophies. Rev Neurol (Paris) 161: 916-931.
56. Sedel F, Lyon-Caen O, Saudubray JM (2007) Inborn errors of metabolism in adult neurology - a clinical approach focused on treatable diseases. Nat Clin Pract Neurol 3: 279-290.
57. Tészas A, Pfund Z, Morava E, et al (2006) Presenile cataract: consider cholestanol. Arch Ophthalmol 124: 1490-1492.
58. Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 116: 811-821.
59. Tourbah A, Stievenart JL, Iba-Zizen MT, et al (1997) Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter. Arch Neurol 54: 586-592.
60. Turpin JC, Paturneau-Jouas M, Sereni C, Pluot M, Baumann N (1985) Adult disclosure of a case of familial adrenoleukodystrophy. Rev Neurol (Paris) 141: 289-295.
61. Van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49: 186-194.
62. Verrips A, Hoefsloot LH, Steenbergen GC, et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123: 908-919.
63. Von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3695-3724.
64. Walk D, Kang SS, Horwitz A (1994) Intermittent encephalopathy, reversible nerve conduction slowing, and MRI evidence of cerebral white matter disease in methylenetetrahydrofolate reductase deficiency. Neurology 44: 344-347.
65. Weglage J, Oberwittler C, Marquardt T (2000) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 23: 83-84.
66. Wenger DA, Suzuki K, Suzuki Y, Suzuki K (2001) Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3669-3694.
67. Willemsen MA, Ijlst L, Steijlen PM, et al (2001) Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 124: 1426-1437.
68. Willemsen MA, Van Der Graaf M, Van Der Knaap MS, et al (2004) MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. Am J Neuroradiol 25: 649-657.
69. Wray SH, Provenzale JM, Johns DR, Thulborn KR (1995) MR of the brain in mitochondrial myopathy. AJNR Am J Neuroradiol 16: 1167-1173.
70. Ziemssen F, Sindern E, Schroder JM, et al (2000) Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol 47: 536-540.